KIN Report

Kindred Biosciences, Inc.
Delisted 2021-08-27
Stock Exchange: NASDAQ
Sector: healthcare
9.25
Last session price
9.25
Price now
Currency: USD
Reporting currency: USD
ISIN: US4945771099
INN:
.

KIN financial statements

* Numbers in thousands
Year
 2014 2015 2016 2017 2018 2019 2020 TTM
Capitalization *
 118 514 65 251 128 181 221 993 305 360 351 392 196 445 363 423
EV *
 105 545 45 259 121 494 187 180 249 058 355 315 205 263 205 263
Stock price $
 6.31 3.3 6.45 8.85 9.85 9.09 5 9.25
Number of shares *
 18 782 19 773 19 873 25 084 31 001 38 657 39 289 39 289
EPS
 -1,44 -1,37 -1,13 -1,23 -1,60 -1,59 -0,55 -0,55
Revenue *
 0 0 0 0 1 966 4 256 42 164 42 164
Net income *
 -27 139 -27 130 -22 499 -30 879 -49 690 -61 389 -21 796 -21 796
Operating profit *
 -27 233 -27 262 -22 169 -31 653 -51 256 -62 567 -15 722 -15 722
Total liabilities *
 2 896 3 248 3 896 6 142 15 275 32 103 28 332 28 332
Net debt *
 -12 969 -19 992 -6 687 -34 813 -56 302 3 923 8 818 8 818
Total assets *
 101 920 79 619 61 576 90 822 106 482 114 024 95 814 95 814
Equity *
 99 024 76 371 57 680 84 680 91 207 81 921 67 482 67 482
Cash and investments *
 101 027 73 043 56 755 81 020 73 932 71 709 58 378 58 378

Over the past 10 years, the maximum capitalization of Kindred Biosciences, Inc. is 351 392, the minimum is 65 251.
Maximum net income 0, Minimum net income -61 389.
The maximum price of KIN shares is 9.85, the minimum price is 3.3.

.

KIN valuation

Year
 2014 2015 2016 2017 2018 2019 2020 TTM
P/E
 -4,37 -2,41 -5,70 -7,19 -6,15 -5,72 -9,01 -16,67
P/B
 1,20 0,85 2,22 2,62 3,35 4,29 2,91 5,39
P/S
 0,00 0,00 0,00 0,00 155,32 82,56 4,66 8,62
E/P
 -23% -42% -18% -14% -16% -17% -11% -6%
P/FCF
 -5,30 -2,78 -6,50 -7,99 -5,18 -5,43 -14,56 -26,93
.

KIN profitability

Year
 2014 2015 2016 2017 2018 2019 2020 TTM
ROE
 -27% -36% -39% -36% -54% -75% -32%
ROA
 -27% -34% -37% -34% -47% -54% -23%
ROIC
 -27% -36% -38% -37% -56% -60% -18%